Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

BioCardia, Inc.

NASDAQ: BCDA · Life Sciences · 9 alerts · CIK 925741

Share price
$0.7901Close, Nov 16
Market cap
$12M
Shares outstanding
15.14MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All BioCardia, Inc. filings on SEC EDGAR ↗

9:00 AM ET 8-K
Clinical Trial Data

BioCardia Clinical Trial Data

BioCardia announced it will present the trial design and scientific support for its CardiAMP HF II Study at the Heart Failure Society of America Annual Scientific Meeting. The study evaluates a high-dose autologous cell treatment for patients with ischemic heart failure of reduced ejection fraction (HFrEF) who remain symptomatic despite medical therapy.

Counterparty
Heart Failure Society of America
4:31 PM ET 8-K
Nasdaq/NYSE Compliance Notice

BioCardia Nasdaq/NYSE Compliance Notice

BioCardia has regained compliance with Nasdaq's $1.00 minimum bid price requirement after its common stock closed at or above $1.00 per share for at least 10 consecutive business days. The company had previously received a deficiency notice on August 19, 2026, and Nasdaq has now officially closed the matter. The company's common stock will continue to trade on The Nasdaq Capital Market under the symbol 'BCDA'.

Counterparty
The NASDAQ Stock Market, LLC

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.